Angela Dardano1, Gayane Aghakhanyan2, Carlo Moretto3, Annamaria Ciccarone1, Rosario Bellini3, Veronica Sancho Bornez1, Giovanni Ceccarini4, Ferruccio Santini4, Duccio Volterrani2, Stefano Del Prato5, Giuseppe Daniele1. 1. Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Nuovo Ospedale Santa Chiara, Pisa, Italy. 2. Regional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine, University of Pisa, Nuovo Ospedale Santa Chiara, Pisa, Italy. 3. Section Bariatric Surgery Unit, Nuovo Ospedale Santa Chiara, Pisa, Italy. 4. Obesity and Lipodystrophy Center, Endocrinology Unit, University of Pisa, Nuovo Ospedale Santa Chiara, Pisa, Italy. 5. Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Diseases, University of Pisa, Nuovo Ospedale Santa Chiara, Pisa, Italy. stefano.delprato@unipi.it.
Abstract
BACKGROUND/ OBJECTIVES: The link between obesity and brain function is a fascinating but still an enigmatic topic. We evaluated the effect of Roux-en-Y gastric bypass (RYGB) on peripheral glucose metabolism, insulin sensitivity, brain glucose utilization and cognitive abilities in people with obesity. SUBJECTS/ METHODS: Thirteen subjects with obesity (F/M 11/2; age 44.4 ± 9.8 years; BMI 46.1 ± 4.9 kg/m2) underwent 75-g OGTT during a [18F]FDG dynamic brain PET/CT study at baseline and 6 months after RYGB. At the same timepoints, cognitive performance was tested with Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Trail making test (TMT) and Token test (TT). Glucose, insulin, C-peptide, GLP-1, GIP, and VIP levels were measured during OGTT. Leptin and BDNF levels were measured before glucose ingestion. RESULTS: RYGB resulted in significant weight loss (from 46.1 ± 4.9 to 35.3 ± 5.0 kg/m2; p < 0.01 vs baseline). Insulin sensitivity improved (disposition index: from 1.1 ± 0.2 to 2.9 ± 1.1; p = 0.02) and cerebral glucose metabolic rate (CMRg) declined in various brain areas (all p ≤ 0.01). MMSE and MoCA score significantly improved (p = 0.001 and p = 0.002, respectively). TMT and TT scores showed a slight improvement. A positive correlation was found between CMRg change and HOMA-IR change in the caudate nucleus (ρ = 0.65, p = 0.01). Fasting leptin decreased (from 80.4 ± 13.0 to 16.1 ± 2.4 ng/dl; p = 0.001) and correlated with CMRg change in the hippocampus (ρ = 0.50; p = 0.008). CMRg change was correlated with cognitive scores changes on the TMT and TT (all p = 0.04 or less). CONCLUSIONS: Bariatric surgery improves CMRg directly related to a better cognitive testing result. This study highlights the potential pleiotropic effects of bariatric surgery. TRIAL REGISTRY NUMBER: NCT03414333.
BACKGROUND/ OBJECTIVES: The link between obesity and brain function is a fascinating but still an enigmatic topic. We evaluated the effect of Roux-en-Y gastric bypass (RYGB) on peripheral glucose metabolism, insulin sensitivity, brain glucose utilization and cognitive abilities in people with obesity. SUBJECTS/ METHODS: Thirteen subjects with obesity (F/M 11/2; age 44.4 ± 9.8 years; BMI 46.1 ± 4.9 kg/m2) underwent 75-g OGTT during a [18F]FDG dynamic brain PET/CT study at baseline and 6 months after RYGB. At the same timepoints, cognitive performance was tested with Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Trail making test (TMT) and Token test (TT). Glucose, insulin, C-peptide, GLP-1, GIP, and VIP levels were measured during OGTT. Leptin and BDNF levels were measured before glucose ingestion. RESULTS: RYGB resulted in significant weight loss (from 46.1 ± 4.9 to 35.3 ± 5.0 kg/m2; p < 0.01 vs baseline). Insulin sensitivity improved (disposition index: from 1.1 ± 0.2 to 2.9 ± 1.1; p = 0.02) and cerebral glucose metabolic rate (CMRg) declined in various brain areas (all p ≤ 0.01). MMSE and MoCA score significantly improved (p = 0.001 and p = 0.002, respectively). TMT and TT scores showed a slight improvement. A positive correlation was found between CMRg change and HOMA-IR change in the caudate nucleus (ρ = 0.65, p = 0.01). Fasting leptin decreased (from 80.4 ± 13.0 to 16.1 ± 2.4 ng/dl; p = 0.001) and correlated with CMRg change in the hippocampus (ρ = 0.50; p = 0.008). CMRg change was correlated with cognitive scores changes on the TMT and TT (all p = 0.04 or less). CONCLUSIONS: Bariatric surgery improves CMRg directly related to a better cognitive testing result. This study highlights the potential pleiotropic effects of bariatric surgery. TRIAL REGISTRY NUMBER: NCT03414333.
Authors: Laura L Ekblad; Juha O Rinne; Pauli Puukka; Hanna Laine; Satu Ahtiluoto; Raimo Sulkava; Matti Viitanen; Antti Jula Journal: Diabetes Care Date: 2017-04-05 Impact factor: 19.112
Authors: Jussi Hirvonen; Kirsi A Virtanen; Lauri Nummenmaa; Jarna C Hannukainen; Miikka-Juhani Honka; Marco Bucci; Sergey V Nesterov; Riitta Parkkola; Juha Rinne; Patricia Iozzo; Pirjo Nuutila Journal: Diabetes Date: 2011-02 Impact factor: 9.461
Authors: Eleni Rebelos; Marco Bucci; Tomi Karjalainen; Vesa Oikonen; Alessandra Bertoldo; Jarna C Hannukainen; Kirsi A Virtanen; Aino Latva-Rasku; Jussi Hirvonen; Ilkka Heinonen; Riitta Parkkola; Markku Laakso; Ele Ferrannini; Patricia Iozzo; Lauri Nummenmaa; Pirjo Nuutila Journal: Diabetes Care Date: 2021-01-14 Impact factor: 19.112